General Information
Revision date
2024-02-16
Product name
Hydrazinomethyl
CAS No.
1263283
REACH No
is
Emergency telephone
+(48
Icons in SDS
Company Information
company name
Merck Life Science Sp.z. o.o
e-mail address of the competent person responsible for the Safety Data Sheet
TechnicalService@merckgroup.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H317, H319
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
SECTION 2: Hazards identification
No 1272/2008 Clasification the substance or mixture Eye irritation ( Category ) H319 Causes serious eye irritation. Skin sensitization ( Category ) H317 May cause allergic skin reaction.
2.2 Label elements
Labelling acording Regulation No
Signal word
Warning Warning
Hazard statements
H317 cause allergic skin reaction. H319 Causes serious eye irritation. Reduced Labeling (<= 125 ml) H317 cause allergic skin reaction.
Precautionary statements
P261 Avoid breathing dust. P264 skin thoroughly after handling. P272 Contaminated work clothing should allowed out of the workplace. P280 Wear protective gloves/ eye protection/ face protection. P302 P352 IF ON SKIN: Wash with plenty of water. P305 P351 P38 IF EYES: Rinse cautiously with water for everal minutes. Remove contact lenses, if present and easy do. Continue rinsing. P261 Avoid breathing dust. P272 Contaminated work clothing should allowed out of the workplace. P302 P352 IF ON SKIN: Wash with plenty of water.
Supplemental label elements
none none
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioacumulative and toxic (PBT), or very persistent and very bioacumulative levels of 0.1% or higher.
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered have endocrine disrupting properties according REACH Article 57(f) or Commision Delegate regulation (EU) 2017/210 or Commision Regulation (EU) 2018/605 levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered have endocrine disrupting properties according REACH Article 57(f) or Commision Delegated regulation (EU) 2017/210 or Commision Regulation (EU) 2018/605 levels of 0.1% or higher. SECTION Composition/information ingredients